Dated market research and perspectives from iPulse AI.
Dated perspectives on companies, asset comparisons, sectors and markets. Each article reflects its stated research dates; use asset pages for the latest published research.
Clear filtersTen pharma and biotech forecasts reveal why the next AI advantage will belong to companies that can turn cheap prediction into clinical evidence, manufacturing, and patient outcomes.
A 12-voice analysis framework ranked 400+ long-horizon opportunities. The best pick showed why upside alone is a dangerous way to read any forecast.
Showing 1–2 of 2
